Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Patient Services Through Digital Appointment Management: Evidence from Dedalus Swiftqueue.

Studies in health technology and informatics·2026
Same author

Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease.

Annals of neurology·2026
Same author

ProCyon: A multimodal foundation model for protein phenotypes.

bioRxiv : the preprint server for biology·2025
Same author

SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis.

Science translational medicine·2025
Same author

Dysregulation of the endosomal sorting complex III is linked to neurodegeneration in progressive multiple sclerosis.

Brain pathology (Zurich, Switzerland)·2025
Same author

Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis.

Brain pathology (Zurich, Switzerland)·2025

Related Experiment Video

Updated: May 21, 2026

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.2K

Digital Pathology Identifies Associations between Tissue Inflammatory Biomarkers and Multiple Sclerosis Outcomes.

Benjamin Cooze1, James Neal1, Alka Vineed1

  • 1Faculty of Medicine, Health & Life and Health Sciences, Swansea University, Swansea SA2 8PP, UK.

Cells
|June 26, 2024
PubMed
Summary

Digital pathology reveals key clinicopathological correlations in multiple sclerosis (MS). This approach helps identify crucial biomarkers for understanding disease progression and patient outcomes in MS.

Keywords:
digital pathologymultiple sclerosisprognosticprogression

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.1K

Related Experiment Videos

Last Updated: May 21, 2026

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.1K

Area of Science:

  • Neuropathology
  • Digital Pathology
  • Neuroimmunology

Background:

  • Multiple sclerosis (MS) is a complex neurological disease characterized by inflammation, demyelination, and neurodegeneration.
  • The heterogeneity of MS pathology varies significantly among individuals and over disease duration.
  • Identifying clinicopathological features linked to disease outcomes is crucial for patient phenotyping in MS.

Purpose of the Study:

  • To investigate the relationship between clinical and neuropathological features in a progressive MS autopsy cohort.
  • To utilize a digital pathology workflow for high-resolution image acquisition and quantification.
  • To correlate digital pathology findings with disease severity and outcomes in progressive MS.

Main Methods:

  • Digital pathology workflow with high-resolution imaging and open-source quantification software.
  • Immunohistochemical staining for myelin (MOG), neurons (HuC/D), and microglia/macrophages (HLA) on sequential brain sections.
  • Analysis of demyelination, neurodegeneration, active/chronic active lesions, and brain/leptomeningeal inflammation in 35 progressive MS cases.

Main Results:

  • Digital analysis demonstrated variable pathological extents characteristic of progressive MS.
  • Microglia/macrophage activation, when detected, was generally widespread across sampled tissue.
  • Compartmentalized inflammation correlated with age-related disease severity and earlier mortality.

Conclusions:

  • Digital pathology successfully identified prognostically significant clinicopathological correlations in MS.
  • This methodology enables the prioritization of key pathological processes for future MS biomarker development.
  • The findings support the use of digital pathology for advancing MS research and clinical understanding.